Kymab Group Limited, a leading monoclonal antibody biopharmaceutical group, announced today that it has received a $9m grant from the Bill & Melinda Gates Foundation to accelerate the development of novel vaccines and therapeutics for infectious diseases, including HIV.
Monoclonal antibody drug discovery focus
Telephone: +44 (0)1223 833 301
Address: Meditrina (B260) Babraham Research Campus Babraham
Post Code: CB22 3AT
Country: United Kingdom
Membership Type: Corporate 51+